Toxicological Sciences 53, 33-39 (2000)
Copyright © 2000 by the Society of Toxicology
Long-Term Toxicity and Carcinogenicity Study of Cyclamate in Nonhuman Primates
* Division of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892;
Clinical Pharmacology Group, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton S016 7PX, United Kingdom;
Department of Pathology and Microbiology and the Eppley Institute for Research on Cancer and Allied Diseases, University of Nebraska, Omaha, Nebraska;
§ Nara Medical University, Kashihara, Nara 634, Japan;
¶ Covance Laboratories America, Inc., Vienna, Virginia 22182;
|| Office of the Director, National Cancer Institute, Bethesda, Maryland 20892.
Twenty-one monkeys (cynomolgus, rhesus, African green) were fed cyclamate (100 mg/kg and 500 mg/kg) in the diet five times per week from a few days after birth and continuing for up to 24 years. Malignant tumors were diagnosed in three 24-year-old cyclamate monkeys; these were metastatic colon carcinoma (rhesus; 500 mg/kg), metastatic hepatocellular carcinoma (cynomolgus; 500 mg/kg), and a small, well differentiated adenocarcinoma of the prostate (cynomolgus; 100 mg/kg). Benign tumors were found at necropsy in three females; these were adenoma of the thyroid gland (rhesus; 100 mg/kg) and two cases of leiomyoma of the uterus (rhesus; 100 mg/kg and 500 mg/kg). No tumors were detected in an age-matched control group of 16 monkeys. Examination of the testes revealed complete testicular atrophy in one of the old cyclamate monkeys, and focal germ cell aplasia (Sertoli-only tubules) in two other cyclamate monkeys. Focal spermatogenic interruption (maturation arrest) at various germ cell levels mixed with normal spermatogenesis was observed in both the cyclamate-treated and the control monkeys, all of which were over 20 years old. Measurements of terminal cyclohexylamine concentrations showed that three of the males dosed with cyclamate at 500 mg/kg were high converters, with plasma concentrations comparable to the levels that produce testicular atrophy in rats. However, only one of the three high converters showed histologic evidence of irregular spermatogenesis. The overall conclusion is that the testicular abnormalities and the sporadic cases of different malignancies found after more than 20 years of dosing do not provide clear evidence of a toxic or carcinogenic effect of sodium cyclamate in monkeys.
Key Words: cyclamate; primates; carcinogen; toxicity; testicular abnormalities; malignancies; spermatogenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. R. Weihrauch and V. Diehl Artificial sweeteners--do they bear a carcinogenic risk? Ann. Onc., October 1, 2004; 15(10): 1460 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Satoh, K. Kai, K. Yabe, F. Fuj, and K. Furuhama Mullerian Tumor (Atypical Polypoid Adenomyoma) with Sex-Cord Differentiation Arising from the Oviduct in an Adolescent Cynomolgus Monkey (Macaca fascicularis) Toxicol Pathol, February 1, 2003; 31(2): 179 - 184. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Huff and L. Tomatis Re: Long-term toxicity and carcinogenicity study of cyclamate in nonhuman primates (Takayama et al., Toxicol. Sci. 53, 33-39) Toxicol. Sci., September 1, 2000; 57(1): 186 - 186. [Full Text] [PDF]
|
|